AU2012244278C1 — Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof
Assigned to Merck Sharp and Dohme LLC · Expires 2014-11-06 · 12y expired
What this patent protects
The invention relates to novel forms of compounds displaying broad spectrum antibiotic activity, especially crystalline polymorphic forms and amorphous forms of such compounds, compositions comprising such crystalline polymorphic forms and amorphous forms of such 5 compounds, pro…
USPTO Abstract
The invention relates to novel forms of compounds displaying broad spectrum antibiotic activity, especially crystalline polymorphic forms and amorphous forms of such compounds, compositions comprising such crystalline polymorphic forms and amorphous forms of such 5 compounds, processes for manufacture and use thereof. The compounds and compositions of the invention are useful in the pharmaceutical industry, for example, in the treatment or prevention of diseases or disorders associated with the use of antibiotics, chemotherapies, or antiviral therapies, including, but not limited to, colitis, for example, pseudo-membranous colitis; antibiotic associated diarrhea; and infections due to Clostridium difficile ("C. difficile"), 10 Clostridiumperfringens ("C. perfringens'", Staphylococcus species, for example, methicillin resistant Staphylococcus, or Enterococcus including Vancomycin-resistant enterococci.
Drugs covered by this patent
- Dificid (FIDAXOMICIN) · Cubist Pharms Llc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.